Stercuronium iodide
Stercuronium iodide (INN, USAN) (developmental code names MYC-1080, MYSC-1080) is an aminosteroid neuromuscular blocking agent which was never marketed.[1][2] It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR), and is also reported to be an acetylcholinesterase inhibitor.[1]
Clinical data | |
---|---|
Other names | MYC-1080; MYSC-1080 |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H43IN2 |
Molar mass | 510.548 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
References
- Kar A (2005). Medicinal Chemistry. New Age International. pp. 175–. ISBN 978-81-224-1565-0.
- Bowden RE, Collier B, Dripps RD, Duchen LW, Enderby GE, Ginsborg BL, Head S, Hobbiger F, Jenkinson DM, MacIntosh, Smith SE (13 March 2013). Neuromuscular Junction. Springer Science & Business Media. pp. 421–. ISBN 978-3-642-45476-9.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.